Galenic formulations of organic compounds

Abstract The present invention relates to a solid unit oral dosage form comprising sacubitril and valsartan in a 1:1 molar ratio, preferably in the form of the so-called angiotensin receptor neprilysin inhibitor (ARNI) LCZ696, which is a complex salt hydrate of sacubitril, valsartan, 5 and sodium io...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Winzenburg, Gesine, Trueby, Bernd, Bush, Christopher, Chen, Fabian, Berkhin, Masha, Ayalasomayajula, Surya Prakash
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!